ID
45967
Descrizione
Principal Investigator: Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA MeSH: Leukemia, Lymphocytic, Chronic, B-Cell https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000879 Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+CD19+ B cells in peripheral lymphoid organs, bone marrow and blood. In this study we analyze matched whole genome sequencing and RNA-seq data from CLL patients to characterize the mutational processes operative throughout tumor evolution. Source of tumor and normal DNA used is patient PBMC or B cells and saliva respectively.
collegamento
Keywords
versioni (1)
- 26/03/24 26/03/24 - Madita Rudolph
Titolare del copyright
Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA
Caricato su
26 marzo 2024
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000879 DFCI Brown Lab CLL Sequencing Study
Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
Similar models
Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
C1299222 (UMLS CUI [1,2])